Hyperphosphatemia Patients on Hemodialysis Clinical Trials in Tokyo
3 recruitingTokyo, Japan
Showing 1–3 of 3 trials
Recruiting
Phase 3
A Clinical Study of TS-172 in Hyperphosphatemia Patients on Hemodialysis
Hyperphosphatemia Patients on Hemodialysis
Taisho Pharmaceutical Co., Ltd.30 enrolled1 locationNCT07548840
Recruiting
Phase 3
A Phase 3 Study of TS-172 in Hyperphosphatemia Patients on Hemodialysis With Phosphate Binders
Hyperphosphatemia Patients on Hemodialysis
Taisho Pharmaceutical Co., Ltd.100 enrolled1 locationNCT07285291
Recruiting
Phase 3
A Long-term Study of TS-172 in Hyperphosphatemia Patients on Hemodialysis
Hyperphosphatemia Patients on Hemodialysis
Taisho Pharmaceutical Co., Ltd.300 enrolled1 locationNCT07285304